Amerise Biosciences (BOM:531681) Beta: 0.8943 (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531681 Amerise Biosciences Ltd BOM:531681
35 GF Score
Price ₹0.86
View Full Analysis

What is Amerise Biosciences Beta?

Amerise Biosciences BOM:531681 35 Beta is 0.8943 as of Aug. 12, 2026. GuruFocus rates BOM:531681 with a GF Score™ of 35/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-12), Amerise Biosciences's Beta is 0.8943.


Amerise Biosciences  (BOM:531681) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Amerise Biosciences Beta Related Terms


Amerise Biosciences Beta Historical Data

* Premium members only.

The historical data trend for Amerise Biosciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amerise Biosciences Beta Chart

Amerise Biosciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 0.06 0.96 0.64 0.66

Amerise Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.64 0.53 0.71 0.68 0.66

BOM:531681 vs XXI, CCXI, DMII: Beta Comparison

For the Shell Companies subindustry, Amerise Biosciences's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amerise Biosciences Beta vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Amerise Biosciences's Beta distribution charts can be found below:

* The bar in red indicates where Amerise Biosciences's Beta falls into.


BOM:531681
35GF Score
Amerise Biosciences Ltd BOM:531681
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amerise Biosciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.8943 mean?
Amerise Biosciences (BOM:531681) has a Beta of 0.8943 as of Aug. 12, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Amerise Biosciences and its competitors.
Is Amerise Biosciences' Beta too high?
Amerise Biosciences' current Beta is 0.8943. Overall, Amerise Biosciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Amerise Biosciences' Beta compare to XXI and CCXI?
Amerise Biosciences' Beta of 0.8943 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Diversified Financial Services company?
A good Beta depends on the Diversified Financial Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Amerise Biosciences and its competitors. Amerise Biosciences's current Beta is 0.8943. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amerise Biosciences stock overvalued right now?
Amerise Biosciences (BOM:531681) has a current Beta of 0.8943. The current Beta is 0.8943. Amerise Biosciences' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Amerise Biosciences (BOM:531681), the current Beta is 0.8943 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amerise Biosciences Business Description

Address Navjeevan Press Road, 24, Laxmi Chambers, Opposite Old Gujarat High Court, Ahmedabad, GJ, IND, 380014
Amerise Biosciences Ltd is an Indian company which is not involved in any business activity.
35GF Score

Get the complete analysis for BOM:531681

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.86
Price